Investor Relations

USA Equities Corp (USAQ)
An Emerging Growth, Medical Device Technology, and Software-as-a-Service (SaaS) Company
We enable independent medical practitioners with digital, value-based tools to proactively address chronic disease and provide preventive care.
USAQ’s approach combines AI-enhanced, connected device technology and clinically proven digital assessments of chronic conditions and health behaviors, providing targeted solutions and a compelling customer value proposition.
Our customer base, geographic footprint, and industry visibility is growing, reinforcing the attractiveness of our recurring revenue business model and large and growing addressable markets.
Our portfolio favorably aligns with industry growth drivers.
Our technology enables physicians to increase their practice revenues.
We offer solutions to meet the need for and acceptance of digital medicine and virtual care.
We have an active pipeline of growth opportunities.
We focus on independent physicians, not large hospital networks or health systems.
Health insurance reimbursements to doctors are on the decline, especially in primary care. Our medical technologies enable physicians to increase their revenue through reimbursable, point-of-care, Software-as-a-Service procedures.
Our platform can support additional digital medicine tools for nutrition, fitness, physical activity, and patient's quality of life, such as sleep, worry, stress, and depression.
Key Metrics
$17B
Large and rapidly growing addressable digital healthcare market
450,000
Number of primary care physicians in the United States that comprise our market opportunity
60M
Number of Americans affected by allergic disorders
>3,000
Practicing allergy specialists in the United States
Our management and medical advisory team have a synergistic mix of industry experience, including comprehensive medical manufacturing and business development backgrounds.
Company Milestones
Press Releases
